Both HIV-1 infection and iron overload are independently associated with infection by Mycobacterium tuberculosis due to impaired macrophage function. A prospective study of in vitro assessment of macrophage function was undertaken in a group of asymptomatic HIV-1 infected remunerated (professional) blood donors with (n = 54) or without (n = 54) prevalent practice of oral iron intake (subgroups I and II respectively). The assessment was carried out at enrolment as well as at the point of development of AIDS related illness (ARI). The subgroup I showed higher levels of pro-inflammatory cytokines viz. IL-1β, IL-6 and IL-8 in serum, but lowered levels of IL-12p70 in serum as well as in supernatant of monocyte derived macrophage (MDM) cultures both at enrolment and at the point of development of ARI in the subset of cases that developed pulmonary tuberculosis (PT) on follow up compared to the subset that developed categories of ARI other than pulmonary tuberculosis (non-PT) on follow up. The subgroup II of HIV-1 positive donors did not show any such alterations at enrolment or at the point of development of PT or non-PT categories of ARI on follow up. There was significant depression of nitrite level in serum as well as that produced by MDM culture at enrolment in subgroup I regardless of category of ARI developed on follow up while in subgroup II there was significant elevation in these levels at enrolment, more among cases developing PT than those developing non-PT category of ARI.
Introduction
Gamma interferon (IFN-γ), a potent pro-inflammatory cytokine secreted by monocytes/macrophages, is considered to play a key role in defense against Mycobacterium tuberculosis infection mediated generation of free radicals like superoxide and nitric oxide [1] [2] [3] . However, production of IFN-γ in turn is regulated by another pro-inflammatory cytokine interleukin 12 (IL-12), also secreted by monocytes/macrophages [4] [5] [6] . In our earlier study on an asymptomatic group of blood donors with human immunodeficiency virus type-1 (HIV-1) infection, the subgroup with history of oral iron intake was found to develop high incidence of pulmonary tuberculosis on follow up (PT) to be shifted after pulmonary tuberculosis from the present location resulting in rapid progression to death, a finding that was considered to be related to deficiency of serum level of IFN-γ detected during early asymptomatic stage of HIV-I infection although status of was not evaluated [7] . Studies have shown that effective defense against M. tuberculosis requires contribution of additional pro-inflammatory cytokines such as interleukin-1 beta (IL-1β), interleukin-6 (IL-6) and interleukin-8 (IL-8) [8] [9] [10] .
Timely recognition of defects in immunity against M. tuberculosis would be of greater relevance at early asymptomatic stage of HIV-1 infection when prophylactic measure against infection due to this agent can be planned. Present report is an extension of the previous report [7] to provide information on serum levels of IL-12p70 (bioactive heterodimeric form of IL-12 in serum) and additional pro-inflammatory cytokines viz. IL-1β, IL-6 and IL-8 along with the status of production of nitric oxide (NO) measured as nitrite, superoxide anion and IL-12p70 by monocyte derived macrophages (MDMs) at asymptomatic stage as well as at the time of development of PT on follow up in HIV-1 infected blood donors in relation to history of oral iron intake.
Materials and Methods

Study Subjects
The details of characterization of subjects included in the present study have been described earlier [7] . Briefly, the study subjects included a group of male remunerated blood donors between 24 -34 years with asymptomatic HIV-1 infection enrolled during 1992-1996 (a period before the introduction of legal ban on remunerated blood donation in the country) (n = 108) having positive (n = 54) or negative (n = 54) history of oral iron consumption (subgroups I and II respectively). A group of HIV negative donors (n = 80) with positive (n = 30) or study also included a group of age, sex and socio-economically matched healthy community controls (n = 40) without any history of blood donation (subgroup V). The ethical clearance of institutional review board and informed consent from the study subjects, were obtained as per standard protocol. Only those HIV-1 positive donors with clinically asymptomatic status, unimpaired blood CD4+ T lymphocyte counts i.e. ≥500 cells/cu mm, normal values in renal and thyroid function tests were included in the same study. All the donors and community controls were screened to exclude sero-positivity for HBV, HCV and Syphilis at enrolment and periodically during the study.
The various subgroups of donors were followed up for development of any AIDS related illness (ARI, stage III) based on WHO criteria [11] . The protocol of follow up for detection of ARI and categorization of ARI into pulmonary tuberculosis (PT) and categories of ARI other than PT (non-PT) has been described earlier [7] .
Blood sample was collected in plain sterile tube to yield serum for estimation of cytokines, nitrite, citrulline and neopterin levels while heparinized blood sample was used for culture of monocytes to yield monocyte derived macrophages (MDMs). Only those HIV-1 seropositive donors from whom blood samples could be collected both at enrolment and at the time of development of ARI were included for analysis of laboratory parameters.
Estimation of Serum Levels of Cytokines
Measurement of levels of pro-inflammatory cytokines viz. IL-1β, IL-6, IL-8 and IL-12p70 in serum was carried out employing commercial reagents and kits (Quantikine, R&D Systems, Minneapolis, USA) with sensitivity levels as 1 pg/ml, 0.70 pg/ml, 3.5 pg/ml and 0.5 pg/ml respectively. The co-efficient of variation was detected to be less than 10% for all the kits and specificity of the kits was crosschecked using heterogeneous recombinant cytokines. Serum sample showing undetectable level of cytokine was ascribed 0 pg/ml value for the purpose of present study.
Estimation of Serum Levels of Nitrite, Citrulline and Neopterin
Estimation of serum levels of nitrite, which is the stable product of nitric oxide (half-life of nitric oxide ~5 -6 sec), was based on Griess reaction [12] . Briefly, serum sample was diluted four fold in distilled water and deproteinised by adding zinc sulfate (final concentration 15 g/L) followed by centrifugation at 10,000 Estimation of serum citrulline level as the surrogate marker to validate production of nitric oxide through arginine utilization pathway was carried out by colorimetric method based on the protocol described by Boyde and Rahmatulla [13] . Briefly, serum sample was deproteinized by adding tricarboxylic acid solution (final concentration 5%) followed by centrifugation. Chromogenic reagent was prepared just before use by adding 5 mg thiosemicarbazide (Sigma Chemicals, USA) to 50 ml of 0.5% diacetyl-monoxime (Sigma Chemicals, USA) solution followed by addition of 100 ml of acid-ferric solution prepared by dissolving FeCl 3 (25 mg) in 100 ml solution containing 25 ml concentrated sulphuric acid (95% -98%), 20 ml concentrated phosphoric acid (85%) and 55 ml distilled water. To 100 µl of supernatant, 3 ml of chromogenic solution was added, mixed vigorously and boiled at 100˚C for 5 minutes. Enzyme urease (Type VII, Sigma Chemicals, USA) was included in the mixture to prevent formation of colour complex by urea with diacetyl-monoxime. The tubes were cooled to room temperature and absorbance was measured at 530 nm in a spectrophotometer.
Quantity of citrulline in supernatant was calculated from a standard curve of absorbance values prepared by running varying dilutions of DL-citrulline (Sigma Chemicals, USA) simultaneously with samples. Representative samples (40%)
were also analyzed by high performance liquid chromatography (HPLC) (Shimadzu Corporation, Japan) to validate detection levels by the colorimetric assay (<5% variation). The detection limit of citrulline was 2.5 µM/L. Serum neopterin level, as a measure of activation of mononuclear phagocytes, was determined by HPLC system (Shimadzu Corporation, Japan) using ultra filtered serum with limit of detection as 0.7 nmol. The optimum protocol for studying the production of nitrite, citrulline, neopterin and IL-12p70 by MDMs in response to challenge with various stimulants was broadly based on the one described earlier [14] . Briefly, in each row of the first microtiter plate, four pairs of wells were seeded with 200 μl of MDM suspension (10 6 /ml) from each sample, out of which three pairs of wells were identified for challenging with three stimulants, one pair/stimulant, while the fourth showing undetectable levels of nitrite or citrulline was regarded as 0 for simplification of analysis [15] .
Detection of
Isolation and Culture of Monocytes for Production of MDMs
Supernatants from second and third pair of wells, stimulated by PMA or SAC respectively were collected for estimation of IL-12p70 by ELISA using reagents from commercial sources (R&D systems, USA) [16] . Briefly, a 96 well polysty- cytokines (e.g. IL-1, IL-2, IL-4 and TNF-α) was detected to be negligible while intra-assay and inter-assay variation was found to be <10%.
2) Detection of superoxide produced by MDM culture
The second microtiter plate was used to study superoxide production by demonstration of superoxide dismutase (SOD)-inhibitable reduction of ferricytochrome C [17] . Three pairs of wells were used per sample, out of which the first pair contained MDMs to be challenged with LPS (1 μg/ml) with or without priming by IFN-γ, the second pair contained MDMs without any challenge with stimulant to serve as cell control while the third pair contained medium only to serve as medium control. The plate was incubated under identical condition and duration as described for the first plate. Before the assay, the medium in the MDM culture was removed from the wells by aspiration and replaced with 1 ml of HBSS and the cells were allowed to stabilize for 15 min at 37˚C before being challenged with a mixture containing 80 µM ferricytochrome C type III (Sigma Chemicals, USA) in HBSS, pH 7.4 and PMA (100 ng/ ml). The microtiter plate was incubated at 37˚C in 5% CO 2 for 90 minute followed by measurement of absorbance at 550 nm. The medium in the cell control well was removed and layered with 100 µl of ferri-cytochrome C supplemented with SOD (30 µg/ml, Sigma chemicals, USA) as a quality check to ensure specificity of superoxide production through SOD-inhibitable cytochrome reduction. The medium control well was checked for spontaneous production of superoxide. Culture medium was also tested for interfering SOD activity by measurement of its ability to inhibit the superoxide production in a superoxide generating system (data not shown). Results were converted to nmol of cytochrome reduced using extinction co-efficient as 21 mM
. Triton X (1%) was added to each well and protein assay was conducted using Lowry method with bovine serum albumin as standard [18] . Results were expressed as nmol of superoxide anion produced/mg of cell protein/minute.
Statistical Analysis
Analysis of various parameters in HIV-1 positive subgroups (subgroup I and II) was undertaken both at enrolment as well as at the point of development of ARI. In the HIV negative subgroups of donors (subgroups III and IV) as well as in HIV negative non-donor community controls (subgroup V), only enrolment samples were included for comparison since no individual in these subgroups developed ARI on follow up.
Comparison of various immunological parameters at enrolment as well as at the time of development of ARI (PT or non-PT) was made by one-way ANOVA followed by positive test with Bonferroni multiple comparisons for continuous variables with normal distribution characteristics. Continuous variables not fol- 
Results
Incidence of ARI
Details of the incidence and category of ARI in various subgroups of donors in relation to history of oral iron intake have been described in the earlier study [7] .
Briefly, the subgroups of HIV-1 positive donors, with history of iron intake had shown significantly higher levels of iron parameters in blood compared to subgroups without history of iron intake i.e. subgroups II and IV that had levels comparable to controls. These findings and the probable mechanism of such high blood iron levels in the iron consuming subgroups was considered to be a reflection of oral iron intake in excess to the physiological requirement [7] .
Serum Levels of Pro-Inflammatory Cytokines
Study of the pro-inflammatory cytokines in serum at enrolment in subgroup I donors showed levels of IL-1β, IL-6 and IL-8 to be elevated among cases that developed PT category of ARI, while their levels were comparable to control group among cases developing non-PT category of ARI. Enrolment levels of these cytokines in serum among the subgroup II of HIV-1 positive donors were comparable to control group regardless whether they developed PT or non-PT category of ARI. Re-assessment of these cytokines at the point of development of ARI in the two subgroups of donors showed continued elevation of their levels at the point of development of PT compared to enrolment levels without any change at the point of development of non-PT category of ARI in subgroup I.
Similar assessment in subgroup II donors continued to show unaltered levels compared to that of enrolment levels regardless of category of ARI developed i.e.
PT or non-PT. Serum levels of IL-12p70 at enrolment was found to be depressed among cases developing PT as well as those developing non-PT category of ARI in both the subgroups I and II although the extent of such depression was more marked in cases developing PT category of ARI compared to non-PT category of ARI in both the subgroups. At the point of development of ARI both subgroups 
Serum Levels of Nitrite, Citrulline and Neopterin
There was significant depression of nitrite, citrulline and neopterin levels in serum at enrolment in subgroup I of HIV-1 positive donors, more marked in those cases that developed PT compared to those developing non-PT category of ARI.
On the contrary, in subgroup II there was significant increase in the levels of these parameters at enrolment, more marked in those cases that developed PT compared to those developing non-PT category of ARI (Table 2) .
At the point of development of ARI on follow up, cases in both subgroups I
and II showed significant elevation of nitrite, citrulline and neopterin levels in serum regardless of category of ARI. The subgroup III donors showed depression of nitrite, citrulline and neopterin levels at enrolment similar to subgroup I Table 1 . Serum level (Mean ± SD) of pro-inflammatory cytokines in various subgroups of blood donors at enrolment and at follow up in relation to category of ARI developed. Table 2 . Serum levels (Mean ± SD) of nitrite, citrulline and neopterin in various subgroups of blood donors at enrolment and at follow up in relation to category of ARI developed. enrolment levels, while the subgroup IV donors showed levels of nitrite, citrulline and neopterin comparable to controls (Table 2 ).
Production of Nitrite, Citrulline and Neopterin by MDMs
Estimation of nitrite as indicator of nitric oxide production by MDM culture in subgroup I revealed significant depression at enrolment in cases developing PT as well as those developing non-PT category of ARI, more marked among former cases compared to later without any effect of priming of MDMs by rIFN-γ.
On the other hand, the subgroup II donors showed increased production of nitrite by MDM culture at enrolment in both categories i.e. those developing PT as well as those developing non-PT ARI with significant augmentation by rIFN-γ priming (Table 3 ).
However at the point of development of ARI, subgroup I donors showed reversal in the pattern of production of nitrite by MDMs in comparison to enrolment status demonstrating increased production in both categories of ARI, more in PT compared to non-PT category, with significant augmenting effect shown by rIFN-γ priming of MDMs. At similar point i.e. at follow up, both PT and non-PT category of cases in subgroup II continued to show comparably higher level of nitrite production by MDMs with augmenting effect by rIFN-γ priming.
The subgroup III donors showed significantly depressed pattern of nitrite production by MDMs at enrolment similar to subgroup I enrolment levels without any effect of rIFN-γpriming, while the subgroup IV donors showed production of nitrite comparable to controls with augmentation in levels induced by rIFN-γ D. Chattopadhya, A. Verghese Table S1 ).
Production of Superoxide Anion by MDMs
Assessment of levels of superoxide anions produced by cultured MDMs at enrolment in subgroup I demonstrated increased level, more marked in those who developed PT compared to those developing non-PT category of ARI, although these increased levels were not further augmented by pre-treatment of MDMs with rIFN-γ. Assessment of superoxide production by MDM at enrolment in subgroup II showed production comparable to controls. However, unlike subgroup I there was appreciable effect of rIFN-γ priming towards boosting of levels recorded at enrolment in both categories regardless of the category of ARI developed (PT or non-PT) on follow up (Table 3) . 
Production of IL-12p70 by MDMs
Production of IL-12p70 by MDMs in subgroup I, following stimulation by PMA, was depressed at enrolment in cases developing PT as well as to those developing non-PT category of ARI, the degree of such depression being more marked in the former category compared to later without any effect of priming by rIFN-γ in either category. In the subgroup II, although some degree of depression could be recorded in the levels of IL-12p70 produced by MDMs at enrolment in the two categories of cases i.e. those developing PT as well as those developing non-PT category of ARI, but unlike the subgroup I both the categories showed enhancement in their levels upon pre-treatment of MDMs by rIFN-γ (Table 4) . Overall patterns of levels of IL-12p70 production by MDMs stimulated by SAC in various subgroups and categories of ARI were similar to the production of MDMs stimulated by PMA although the degree of changes was set at higher level in case of stimulation by SAC compared to PMA (Table 4 ).
Correlation of Serum Ferritin Level and Production of Nitrite, Superoxide and IL-12p70 by MDMs at Enrolment in Iron Consuming Subgroup of HIV-1 Positive Donors (Subgroup I)
It was observed that level of ferritin in serum at enrolment had significant nega- 
Discussion
In the present study serum levels of all three pro-inflammatory cytokines viz.
IL-1β, IL-6 and IL-8 were found to be elevated at baseline in HIV-1 positive blood donors with history of oral iron intake reflecting state of immune activation induced by high serum iron. These findings are in agreement with the elevated levels of immune activation markers i.e. TNF-α, TNFR1 and TNFRII reported earlier in the same iron consuming subgroup of HIV-1 positive donors [7] . Co-infection with tuberculosis and HIV has been reported to lead to a syn- previous study [7] .
In the present study pattern of changes in the levels of nitrite in serum among the iron consuming and non-iron consuming subgroups of HIV-1 positive donors correlated with that observed in MDM cultures in the corresponding subgroups suggesting the later as the possible source of former. HIV-1 infection, even at early stage, has been reported to be associated with increased nitrite production positively correlating with plasma and cell associated virus. HIV-1 protein e.g. Tat has been found to enhance transcription of iNOS by direct effect [21] . In the simian immune-deficiency virus/macaque model, significantly increased concentration of nitrite could be demonstrated in plasma during primary infection, co-incident with viraemia peaks even in the absence of opportunistic infections [22] . These reports corroborate with the finding of increased level of nitrite in the HIV-1 infected donors without any history of iron intake (subgroup II). On the contrary, nitrite level was found to be depressed in HIV-1 infected donors with history of iron intake (subgroup I) at enrolment regardless of whether they developed PT or non-PT category of ARI on follow up. Increased level of iron reduces the production of nitrite by preventing activation of the transcription factor Nuclear Factor Interleukin 6 (NF-IL-6) that regulates iNOS expression [23] . Depressed nitrite level in HIV-1 infected subgroup consuming oral iron could also be a result of enhanced Nuclear Factor Kappa Beta (NF-kβ)
production that is capable of binding to iNOS leading to decreased nitrite pro- [24] . It is likely that depressed nitrite production detected in subgroup I donors with increased serum iron overload reflected relatively more powerful inhibitory effect of iron on nitrite production than any stimulatory effect by HIV-1/HIV-1 proteins. However, considering the fact that among the subgroup I donors, those developing PT on follow up had significantly higher degree of depression of nitrite level at enrolment compared to those developing non-PT category of ARI on follow up and overall incidence of PT in the same subgroup of donors was found to be higher compared to non-iron consuming subgroup of HIV-1 positive donors, it may be tempting to postulate that depressed nitrite production might have been responsible for greater susceptibility to M. tuberculosis due to impaired macrophage mediated defense in this subgroup.
Increased production of nitrite at the point of development of ARI in HIV-1infection, as observed in the present study, has also been observed by other workers [25] . Greater production of nitrite among PT cases in HIV-1 positive donors consuming iron compared to those without such practice may be related to shorter post -PT survival among former subgroup compared to later. It has been postulated that nitrite oxide (NO), the active unstable precursor of NO 2 is produced in the lung during various processes like vascular regulation and as a consequence of host defense by various cell types like alveolar macrophages, bronchial and alveolar epithelial cells, endothelial cells and fibroblasts [26] .
Nitrite measured in-vitro MDM culture is likely to be a true reflection of its production by cultured macrophage rather than contribution by non-macrophage components in tissue culture e.g. fetal calf serum [27] since the present study utilized surrogate markers of iNOS mediated pathway for NO production i.e. citrulline and neopterin, levels of both of which correlated with the levels of nitrate, substantiating specificity of the assay employed in the present study for . While it is conceivable that increased incidence of M. tuberculosis in the iron consuming subgroup of HIV-1 infected donors may be related to impaired production of nitric oxide by macrophages as explained earlier, it may be apparently paradoxical to encounter increased superoxide production in the same subgroup which is considered instrumental in killing mycobacteria [30] [31] [32] . In fact, increased production of reactive oxygen species (ROS) by iron D. Chattopadhya, A. Verghese excess may be detrimental to the host cell itself through induction and acceleration of programmed cell death thereby reducing the survival probability of intracellular organism like mycobacteria [33] . There could be several possibilities which might explain immunity of M. tuberculosis to survive in this scenario.
Firstly, mycobacterial products like sulfatides and lipoarabinomanan (LAM) can scavenge reactive oxygen intermediates (ROI) or inhibit the respiratory burst that generates them [34] . Secondly, pathogenic mycobacteria reportedly produce large amounts of iron co-factored superoxide dismutase (SOD) capable of detoxifying superoxide anion thereby contributing to virulence of M. tuberculosis [35] . Furthermore, M. tuberculosis can enter macrophages via complement receptors, thereby avoiding an oxidative burst [36] . These data suggest that ROS maybe a less powerful antimicrobial tool against M tuberculosis strains in vivo compared to nitric oxide [37] .
However, higher incidence of PT in the iron consuming subgroup of HIV-1 infected donors could be an independent direct effect of iron apart from indirect effects through alteration of nitrite/superoxide production. Direct evidence includes demonstration of obligatory requirement of iron for growth of M. tuberculosis in vitro [38] , epidemiological evidence includes association between iron overload and pulmonary tuberculosis [39] and genetic evidence shows link between susceptibility of iron overload and tuberculosis [40] while indirect evidence is provided by reported inhibition of growth of M. tuberculosis by exogenous chelator [30] and improved clinical outcome in patients with iron overload on administration of chelators [41] .
In the present study production of IL-12p70 was found to be markedly deficient at enrolment in the subgroups of donors consuming oral iron as evident from their levels in serum as well as in MDM culture supernatant regardless of whether they developed PT or non-PT category of ARI on follow up, although the degree of depression was significantly more marked in the former category compared to later. Decreased level of IL-12p70 is more likely to be a direct effect of high serum iron rather than deficiency of cooperative effect by cytokine IFN-γ since treatment of purified MDMs by IFN-γ did not have any effect on IL-12p70 production on PMA or SAC stimulation. Iron overload has been reported to depress production of IL-12 through negative effect on 1L-12 gene expression [42] .
There is evidence of defective production of IL-12 in early stage of HIV-1 infection [43] . However, greater magnitude of deficiency in IL-12 production refractory to priming effect by rIFN-γ observed at enrolment in the iron consuming subgroup of HIV-1 positive donors that showed development of PT in high proportion (>70%) of cases on follow up suggest a relationship between reduced level of IL-12 and increased susceptibility to M. tuberculosis. It has been reported that rIL-12 administration increases and rIL-12 neutralization decreases resistance to M. tuberculosis [44] . Treatment with rIL-12 delays lung pathology in M. tuberculosis infected mice [45] which highlights a possible link between IL-12 deficiency and rapid post-PT disease progression reported earlier in the D. Chattopadhya, A. Verghese Journal of Biosciences and Medicines same subgroup with iron overload [7] .
In the present study, the subgroup of donors negative for HIV- of iron for prophylactic use e.g. to correct anemia during pregnancy [46] .
